AMANDA KRANTZ: Open Payments
NPI 1164082988 · COQUILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $84
Food & beverage: $84
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $26 |
Products named: AREXVY, LEQVIO, REZDIFFRA.
Industry payments across OR — which companies pay providers there.
